Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891414550> ?p ?o ?g. }
- W2891414550 endingPage "222" @default.
- W2891414550 startingPage "213" @default.
- W2891414550 abstract "Triple-negative breast cancer (TNBC) represents a clinical challenge because it lacks sensitivity to hormone therapy or other available molecule-targeted agents. In addition, TNBC frequently exhibits over-activation of the PI3K/Akt survival pathway that can contribute to chemotherapy resistance. 4β-Hydroxywithanolide E (4-HW) and withaferin A (WA) are two withanolides from Solanaceae plants that exhibit promising anticancer activity in vitro and in vivo.The aim of this study is to investigate and compare the effects of 4-HW and WA on TNBC cells and underling mechanisms.The anticancer effects of 4-HW and WA were evaluated by cell viability, cell cycle arrest, and apoptosis assays. PI3K/Akt signaling and the expression of survivin, Bcl-2 family proteins and cyclin-dependent kinase inhibitors were evaluated by Western blot. The role of PI3K/Akt signaling in the withanolides-induced anticancer effects was examined by using a PI3K inhibitor and overexpression of a constitutively active form of Akt.In TNBC MDA-MB-231 cells, 4-HW and WA displayed different kinetic effect on cell availability. Cell cycle analysis revealed that 4-HW induced the G1-phase arrest while WA caused the G2/M-phase block. Both withanolides induced apoptosis, but WA also caused necrosis. 4-HW inhibited the PI3K/Akt pathway and survivin expression as well as up-regulated the cyclin-dependent kinase inhibitors p21 and p27. In contrast, WA is a more potent inhibitor of Hsp90 and elicited Akt activation at low doses but inhibited Akt signaling at higher doses by depleting the Akt protein. The PI3K inhibitor LY294002 mimicked the effects of 4-HW and potentiated the cytotoxic activity of WA. In contrast, overexpressing a constitutively active form of myristoylated Akt rescue cancer cells from 4-HW-induced cell death.The withanolides 4-HW and WA potently inhibit the viability of TNBC cells through induction of cell cycle arrest and apoptosis/necrosis. The PI3K/Akt pathway plays distinct roles in cancer cells respond to 4-HW and WA. These results suggest the potential applications of the withanolides for the treatment of TNBC." @default.
- W2891414550 created "2018-09-27" @default.
- W2891414550 creator A5007869987 @default.
- W2891414550 creator A5012390608 @default.
- W2891414550 creator A5066399911 @default.
- W2891414550 creator A5070657366 @default.
- W2891414550 creator A5071552817 @default.
- W2891414550 creator A5075528541 @default.
- W2891414550 creator A5081033319 @default.
- W2891414550 date "2019-02-01" @default.
- W2891414550 modified "2023-09-29" @default.
- W2891414550 title "Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells" @default.
- W2891414550 cites W1924319313 @default.
- W2891414550 cites W1964576770 @default.
- W2891414550 cites W1975707478 @default.
- W2891414550 cites W1976643149 @default.
- W2891414550 cites W1976980728 @default.
- W2891414550 cites W1983927645 @default.
- W2891414550 cites W1984298207 @default.
- W2891414550 cites W1984722635 @default.
- W2891414550 cites W1988359009 @default.
- W2891414550 cites W1998926494 @default.
- W2891414550 cites W2001872187 @default.
- W2891414550 cites W2007561185 @default.
- W2891414550 cites W2024880968 @default.
- W2891414550 cites W2026710188 @default.
- W2891414550 cites W2035258932 @default.
- W2891414550 cites W2036521316 @default.
- W2891414550 cites W2039037322 @default.
- W2891414550 cites W2040843618 @default.
- W2891414550 cites W2041511542 @default.
- W2891414550 cites W2049763771 @default.
- W2891414550 cites W2050380934 @default.
- W2891414550 cites W2074579328 @default.
- W2891414550 cites W2077080951 @default.
- W2891414550 cites W2106281303 @default.
- W2891414550 cites W2114735994 @default.
- W2891414550 cites W2124818074 @default.
- W2891414550 cites W2132299300 @default.
- W2891414550 cites W2135967493 @default.
- W2891414550 cites W2168390839 @default.
- W2891414550 cites W2327334207 @default.
- W2891414550 cites W2460207510 @default.
- W2891414550 cites W375413697 @default.
- W2891414550 doi "https://doi.org/10.1016/j.phymed.2018.09.017" @default.
- W2891414550 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30668401" @default.
- W2891414550 hasPublicationYear "2019" @default.
- W2891414550 type Work @default.
- W2891414550 sameAs 2891414550 @default.
- W2891414550 citedByCount "26" @default.
- W2891414550 countsByYear W28914145502019 @default.
- W2891414550 countsByYear W28914145502020 @default.
- W2891414550 countsByYear W28914145502021 @default.
- W2891414550 countsByYear W28914145502022 @default.
- W2891414550 countsByYear W28914145502023 @default.
- W2891414550 crossrefType "journal-article" @default.
- W2891414550 hasAuthorship W2891414550A5007869987 @default.
- W2891414550 hasAuthorship W2891414550A5012390608 @default.
- W2891414550 hasAuthorship W2891414550A5066399911 @default.
- W2891414550 hasAuthorship W2891414550A5070657366 @default.
- W2891414550 hasAuthorship W2891414550A5071552817 @default.
- W2891414550 hasAuthorship W2891414550A5075528541 @default.
- W2891414550 hasAuthorship W2891414550A5081033319 @default.
- W2891414550 hasConcept C142724271 @default.
- W2891414550 hasConcept C184235292 @default.
- W2891414550 hasConcept C185592680 @default.
- W2891414550 hasConcept C190283241 @default.
- W2891414550 hasConcept C199835354 @default.
- W2891414550 hasConcept C204787440 @default.
- W2891414550 hasConcept C2775975398 @default.
- W2891414550 hasConcept C2776598214 @default.
- W2891414550 hasConcept C2780069950 @default.
- W2891414550 hasConcept C29537977 @default.
- W2891414550 hasConcept C502942594 @default.
- W2891414550 hasConcept C55493867 @default.
- W2891414550 hasConcept C62478195 @default.
- W2891414550 hasConcept C71924100 @default.
- W2891414550 hasConcept C75217442 @default.
- W2891414550 hasConcept C86554907 @default.
- W2891414550 hasConcept C86803240 @default.
- W2891414550 hasConcept C95444343 @default.
- W2891414550 hasConceptScore W2891414550C142724271 @default.
- W2891414550 hasConceptScore W2891414550C184235292 @default.
- W2891414550 hasConceptScore W2891414550C185592680 @default.
- W2891414550 hasConceptScore W2891414550C190283241 @default.
- W2891414550 hasConceptScore W2891414550C199835354 @default.
- W2891414550 hasConceptScore W2891414550C204787440 @default.
- W2891414550 hasConceptScore W2891414550C2775975398 @default.
- W2891414550 hasConceptScore W2891414550C2776598214 @default.
- W2891414550 hasConceptScore W2891414550C2780069950 @default.
- W2891414550 hasConceptScore W2891414550C29537977 @default.
- W2891414550 hasConceptScore W2891414550C502942594 @default.
- W2891414550 hasConceptScore W2891414550C55493867 @default.
- W2891414550 hasConceptScore W2891414550C62478195 @default.
- W2891414550 hasConceptScore W2891414550C71924100 @default.
- W2891414550 hasConceptScore W2891414550C75217442 @default.
- W2891414550 hasConceptScore W2891414550C86554907 @default.
- W2891414550 hasConceptScore W2891414550C86803240 @default.